Genomic Analysis Reveals Hypervirulent Listeria Markers Linked to Fatal Outcomes

Can Genomic Insights Advance Listeriosis Management?

The detailed genomic analysis of three novel Listeria monocytogenes strains has revealed critical insights into their virulence potential, antimicrobial resistance profiles, and evolutionary adaptations. This comprehensive study, which employed a hybrid sequencing approach combining Oxford Nanopore long-read and Illumina short-read technologies, provides valuable information for clinical management strategies and food safety protocols in the ongoing battle against listeriosis, a severe foodborne disease with high mortality rates among vulnerable populations.

Which Methodologies Unveil the Genetic Blueprint?

Researchers examined one environmental isolate (C5) from a dairy farm setting and two clinical isolates (A2D9 and A2D10), with the latter associated with a fatal outcome. The hybrid sequencing approach yielded high-quality genome assemblies with excellent completeness (>99.9%) and minimal contamination (<1%), enabling precise characterization of genomic features across all three strains. The genomes displayed remarkable consistency in their basic architecture, each containing approximately 2,800-2,900 protein-coding sequences with a GC content of 38%, aligning with previously reported values for L. monocytogenes.

Phylogenomic analysis revealed interesting relationships between the strains. Average nucleotide identity (ANI) comparisons exceeded 98% across all pairwise comparisons, confirming their taxonomic positioning within L. monocytogenes. Notably, strain A2D9 showed closer genomic similarity to the reference strain EGD-e, while C5 and A2D10 formed a separate phylogenetic cluster. Multilocus sequence typing (MLST) assigned strain C5 to sequence type ST2 of clonal complex CC2, A2D9 to ST155 of CC155, and most significantly, A2D10 to ST1 of hypervirulent CC1, which has been previously associated with severe clinical outcomes. This classification aligns with the fatal outcome linked to the A2D10 strain and underscores the clinical relevance of sequence typing in predicting virulence potential.

Does the Pan-Genome Reveal Adaptive Strategies?

The comparative genomic analysis demonstrated that approximately 80% of genes constitute the core genome shared across all strains, with the remaining 20% representing the accessory genome that contributes to strain-specific adaptations. The pan-genome analysis revealed a continuous expansion with each additional genome, suggesting substantial genomic diversity within L. monocytogenes. Each strain possessed unique genes ranging from 47 to 93 sequences that were absent in the other isolates, potentially contributing to their ecological adaptability and pathogenic versatility. Functional annotation through KEGG pathways and COG categories showed that most genes were involved in fundamental metabolic processes, while the distribution of singletons suggested strain-specific functions that may contribute to environmental persistence or host adaptation.

What Genetic Determinants Drive Virulence, Resistance, and Defense?

A key finding of this study was the identification of virulence determinants that differentiate the strains. All three isolates harbored the Listeria pathogenicity island 1 (LIPI-1), which includes essential virulence genes such as prfA, plcA, plcB, hly, actA, and mpl required for intracellular survival and cell-to-cell spread. Multiple internalin genes (inlA, inlB, inlC, inlF, and inlK) were also present across all strains, facilitating host cell invasion. Notably, strain A2D10 uniquely contained the complete lls gene cluster forming the Listeria pathogenicity island 3 (LIPI-3), which encodes listeriolysin S, a virulence factor associated with enhanced pathogenicity in hypervirulent strains. This finding provides a potential molecular explanation for the fatal outcome associated with this particular strain and highlights the importance of genomic surveillance in clinical settings.

Antimicrobial susceptibility testing revealed consistent resistance profiles across all three strains. They exhibited resistance to cefoxitin, oxacillin, daptomycin, and moxifloxacin, intermediate susceptibility to ciprofloxacin, and sensitivity to critical therapeutic agents including ampicillin, benzylpenicillin, gentamicin, erythromycin, and vancomycin. Genomic screening identified intrinsic resistance genes such as fosX (fosfomycin resistance), norB (fluoroquinolone resistance), mprF (resistance to cationic antimicrobial peptides), and lin (lincosamide resistance), as well as the multidrug efflux pump gene mdrL. These findings confirm the typical antimicrobial profile of L. monocytogenes and support the continued use of ampicillin or benzylpenicillin as first-line therapy in clinical practice, while underscoring the importance of ongoing genomic surveillance for emerging resistance mechanisms.

The analysis of defense mechanisms revealed diverse systems across the strains, including restriction-modification (R-M) systems in C5, A2D10, and EGD-e, a CRISPR-Cas Type IB system in A2D9, and abortive infection (Abi) systems in A2D10 and EGD-e. These variations in defense mechanisms, along with differences in prophage regions and genomic islands, highlight the genomic plasticity of L. monocytogenes and its capacity for horizontal gene transfer and adaptation to diverse ecological niches. The presence of these systems may contribute to the survival and persistence of these strains in food processing environments and during host infection, presenting challenges for control strategies.

Could These Genomic Insights Transform Clinical and Food Safety Practices?

This comprehensive genomic characterization of novel L. monocytogenes strains provides valuable insights for both clinical management and food safety protocols. The identification of hypervirulent markers, such as LIPI-3 in strain A2D10, could potentially be used to predict severe clinical outcomes and guide therapeutic interventions. Similarly, the confirmation of antimicrobial susceptibility profiles supports current treatment guidelines while highlighting the importance of continued surveillance. From a food safety perspective, understanding the genomic basis of environmental persistence and virulence potential can inform more targeted control strategies in food processing environments. Could these findings shift current approaches to molecular surveillance in food production facilities, particularly in dairy environments where these strains show genomic similarity to previously isolated pathogens?

While this study provides comprehensive genomic characterization, it's important to note that the findings are based on bioinformatic predictions and would benefit from experimental validation of the identified virulence factors, resistance mechanisms, and defense systems. Future research should focus on elucidating the functional significance of strain-specific genomic features and their contribution to L. monocytogenes virulence and environmental adaptation. As whole-genome sequencing becomes more accessible and integrated into routine surveillance, how might we leverage this technology to establish early warning systems for emerging hypervirulent or multidrug-resistant L. monocytogenes strains before they cause widespread outbreaks? What regulatory frameworks might need adaptation to incorporate genomic data into food safety risk assessments?

The genomic plasticity observed in these strains raises important questions about the evolution and adaptation of L. monocytogenes in response to selective pressures in food production environments and during host infection. To what extent do food processing interventions, such as sanitizers and preservatives, drive the selection of genetic traits that inadvertently enhance virulence or stress tolerance? Additionally, as climate change alters global food production systems and supply chains, how might these environmental shifts influence the genomic evolution and geographical distribution of virulent L. monocytogenes strains? These questions underscore the importance of continued genomic surveillance and functional characterization to address the ongoing public health challenges posed by this formidable foodborne pathogen.

Summary

A comprehensive genomic study of three novel Listeria monocytogenes strains has provided critical insights into the molecular basis of listeriosis virulence and antimicrobial resistance. Using hybrid sequencing technology combining Oxford Nanopore and Illumina platforms, researchers analyzed one environmental isolate from a dairy farm and two clinical isolates, one associated with a fatal outcome. The analysis revealed that all strains shared the core Listeria pathogenicity island 1 (LIPI-1) containing essential virulence genes, while the fatal strain A2D10 uniquely harbored LIPI-3 encoding listeriolysin S, a marker of hypervirulence. Multilocus sequence typing classified A2D10 as ST1 within the hypervirulent clonal complex CC1, providing molecular explanation for its severe clinical outcome. All strains demonstrated consistent antimicrobial resistance profiles, showing resistance to cefoxitin, oxacillin, daptomycin, and moxifloxacin, while remaining susceptible to first-line therapeutic agents including ampicillin and benzylpenicillin. Genomic analysis identified intrinsic resistance genes and multidrug efflux pumps, confirming the typical resistance profile of L. monocytogenes. The pan-genome analysis revealed that approximately 80% of genes constitute the core genome, with the remaining 20% representing strain-specific adaptations contributing to ecological versatility and pathogenic potential. Each strain possessed unique gene sequences potentially enhancing environmental persistence or host adaptation. The study also documented diverse defense mechanisms including restriction-modification systems, CRISPR-Cas systems, and prophage regions, highlighting the genomic plasticity and horizontal gene transfer capacity of L. monocytogenes. These findings support the continued use of ampicillin as first-line therapy and underscore the importance of genomic surveillance for predicting clinical outcomes and informing food safety protocols. The identification of hypervirulent markers could potentially guide therapeutic interventions and risk assessments in food processing environments, particularly in dairy settings where environmental persistence poses ongoing challenges.